JamesToddRosenbaumMD

Senior Vice-President for Research, Corvus Pharmaceuticals, Burlingame, CA.; Richard Chenoweth Professor Emeritus, Legacy Devers Eye Clinic, Portland, OR.

Join to view full profile

Dr. Rosenbaum is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Rosenbaum's full profile

Already have an account?

Office
3181 SW Sam Jackson Park Rd
L467ad
Portland, OR 97239
Phone+1 503-494-5023

Fax+1 503-494-6875

Summary

I am a board certified rheumatologist with special expertise in ocular inflammatory diseases. I am currently employed full-time as the Senior Vice-President for Research at Corvus Pharmaceuticals. I see patients one half day per week at Legacy Devers Eye Clinic in Portland, OR. This clinic is a joint undertaking with a retina specialist, Sirichai Pasadhika, and provides care for patients with ocular inflammatory diseases.

Education & Training

Stanford Health Care-Sponsored Stanford UniversityFellowship, Allergy and Immunology, 1978 - 1981
Stanford Health Care-Sponsored Stanford UniversityResidency, Internal Medicine, 1975 - 1978
Yale School of MedicineClass of 1975
Harvard UniversityAB, Social Relations, Magna Cum Laude, Phi Beta Kappa, 1967 - 1971

Certifications & Licensure

OR State Medical License 1985 - 2025
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Rheumatology

Awards, Honors, & Recognition

Manfred Zierhut Teaching Award International Uveitis Study Group, 2024
Innovative Research Award Rheumatology Research Foundation, American College of Rheumatology, 2018-2020, 2022-2024
Distinguished Service Award American College of Rheumatology, 2022
Research Career Achievement Award Spondylitis Research and Treatment Network (SPARTAN), 2022
Edward E Rosenbaum Endowed Professorship Oregon Health & Science University, 2001-2022
Volunteer Physician of the Year Spondylitis Association of America, 2021
Richard Chenoweth Endowed Scientist Legacy Devers Eye Institute, 2012-2019
Dunlop Dottridge Annual Lecture Canadian Rheumatology Association, 2015
Scholar Alcon Research Institute, 2015
Von Szily Medal German Ophthalmological Society, 2014
Distinguished Clinician Scientist Award American College of Rheumatology, 2013
Cless Award University of Illinois, Chicago, 2012
Gold Medal International Uveitis Study Group Foundation, 2012
Friedenwald Award Association for Research in Vision and Ophthalmology, 2011
Elected member Association of American Physicians, 2005
Dean's Award for Excellence in Teaching Oregon Health & Science University, 2002
Discovery Award Medical Research Foundation of Oregon, 2001
Senior Scholar Award Research to Prevent Blindness, 1994
Dolly Green Scholar Award Research to Prevent Blindness, 1986
CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2013
Elected Member The American Society for Clinical Investigation, 1994
Join now to see all

Clinical Trials

A Clinical Trial of Infliximab for Uveitis Start of enrollment: 2001 Aug 01
Completed
Not Applicable
Rituximab in the Treatment of Scleritis and Non-Infectious Orbital Inflammation Start of enrollment: 2007 Jan 01
Completed
Phase 1, Phase 2
Adalimumab (Humira) in the Treatment of Refractory Non-infectious Uveitis Start of enrollment: 2008 Jan 01
Completed
Phase 2
Uveitis Gene-Expression Profiling Start of enrollment: 2005 Jun 01
Completed
Abatacept in the Treatment of Uveitis Start of enrollment: 2012 Jan 01
Completed
Phase 2
Tocilizumab in the Management of Juvenile Idiopathic Arthritis Associated Uveitis Start of enrollment: 2013 Nov 01
Terminated
Phase 1, Phase 2
Optical Coherence Tomography (OCT) in Uveitis Start of enrollment: 2012 Mar 01
Recruiting
OCT in Rare Chorioretinal Diseases Start of enrollment: 2014 May 01
Recruiting
Join now to see all

Publications & Presentations

PubMed

13 citations
Methotrexate as a Corticosteroid-Sparing Agent for Thyroid Eye Disease.
Erick Rivera-Grana, Phoebe Lin, Eric B. Suhler, James T. Rosenbaum
Journal of Clinical & Experimental Ophthalmology. 2015-04-27
3094 citations
Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop.
Douglas A. Jabs, Robert B. Nussenblatt, James T. Rosenbaum
American Journal of Ophthalmology. 2005-09-01
47 citations
Long-Term Safety of Adalimumab in 29,967 Adult Patients From Global Clinical Trials Across Multiple Indications: An Updated Analysis.
Gerd R Burmester, Kenneth B. Gordon, James T. Rosenbaum, Dilek Arikan, Winnie Lau
Advances in Therapy. 2020-01-01

Journal Articles

Community Profiling of the Urinary Microbiota: Considerations for Low-Biomass Samples
Rahel Nardos, James T Rosenbaum, Nature

Other

The Microbiome and HLA-B27-Associated Acute Anterior Uveitis
James Rosenbaum, MD, Nature
https://www.doximity.com/articles/d1bfcca6-0f9a-4396-941e-5ab321714e62
UpToDate, Wolters Kluwer Health - 2012-02-25
The Microbiome and HLA-B27-Associated Acute Anterior Uveitis
James Rosenbaum, MD, Nature
https://www.doximity.com/articles/d1bfcca6-0f9a-4396-941e-5ab321714e62
UpToDate, Wolters Kluwer Health - 2012-12-05

Press Mentions

ITK Inhibition with Soquelitinib Induced Switching of Proinflammatory ThJuly 25th, 2024
James Rosenbaum Presented the Distinguished Service Award by the American College of RheumatologyNovember 14th, 2022
The Rising Toll of Autoimmune Diseases in Older PeopleAugust 10th, 2021
Join now to see all

Grant Support

Ophthalmology Core FacilityNational Eye Institute1995–2012
Understanding Uveitis In A Multi-System Disease Model Of SpondyloarthropathyNational Eye Institute2011
Gene Expression In Nonspecific Orbital Inflammatory DiseaseNational Eye Institute2011
Endotoxin-Induced Uveitis RevisitedNational Eye Institute2009–2010
Four Dimensional Imaging Of The Immune Response In VivoNational Eye Institute1999–2010
Uveitis Gene-Expression ProfilingNational Eye Institute2005–2008
Chemotactic Factors In Animal Models Of UveitisNational Eye Institute1986–2008
Immunology/Molecular Biology Training In OphthalmologyNational Eye Institute1991–2007
Uveitis Gene-Expressoin ProfilingNational Eye Institute2006
"Remicade" In The Management Of Vision-Threatening UveitisNational Center For Research Resources2004–2005
Anterior Uveal Dendritic CellsNational Eye Institute2001–2004
Opthalmology Core FacilityNational Eye Institute2000–2004
Four Dimentional Imaging Of The Immune Response In VivoNational Eye Institute2000–2003
Chemotactic Factors In Models Of UveitisNational Eye Institute1994–2003
Ophthalmology Core Facility SupplementNational Eye Institute2001
Utility Of Intravenous Immunoglobulin In The Treatment Of UveitisNational Center For Research Resources1997–2001
Endotoxin Induced UveitisNational Eye Institute1985–2000
Core--Tissue CultureNational Eye Institute1997–1999
Endotoxin-Induced UveitisNational Eye Institute1987–1996
Growth Factors In Proliferative VitreoretinopathyNational Eye Institute1989–1992